INTERMITTENT INTRA-ARTERIAL INFUSION TREATMENT OF SEVERE INTERMITTENT CLAUDICATION - RESULTS OF A PROSPECTIVE DOUBLE-BLIND-STUDY OF PROSTAGLANDIN-E1 VERSUS ENERGY-RICH PHOSPHATES

被引：0
|
作者：
CREUTZIG, A
CASPARY, L
RADEKE, U
SPECHT, S
ALEXANDER, K
机构：
来源：
VASA-JOURNAL OF VASCULAR DISEASES | 1988年
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：133 / 135
页数：3
相关论文
共 12 条
  • [1] INTERMITTENT INTRAARTERIAL INFUSION THERAPY OF SEVERE CLAUDICATION - PROSTAGLANDIN-E1 VS ENERGY RICH PHOSPHATES
    CREUTZIG, A
    CASPARY, L
    RADEKE, U
    SPECHT, S
    RANKE, C
    ALEXANDER, K
    MEDIZINISCHE KLINIK, 1988, 83 (13-14) : 434 - 438
  • [2] INTERMITTENT INTRAARTERIAL INFUSION THERAPY WITH PGE1 IN PATIENTS WITH SEVERE CLAUDICATION - RESULTS OF A RANDOMIZED PROSPECTIVE DOUBLE-BLIND STUDY
    CASPARY, L
    CREUTZIG, A
    RADEKE, U
    SPECHT, S
    ALEXANDER, K
    BIOMEDICA BIOCHIMICA ACTA, 1988, 47 (10-11) : S307 - S310
  • [3] Efficacy of a new prostaglandin E(1) regimen in outpatients with severe intermittent claudication: Results of a multicenter placebo-controlled double-blind trial
    Diehm, C
    Balzer, K
    Bisler, H
    Bulling, B
    Camci, M
    Creutzig, A
    Gruss, JD
    Horsch, S
    Odemar, F
    Piehler, U
    Rogatti, W
    Scheffler, P
    Spengel, F
    Treese, N
    Turowski, A
    Waldhausen, P
    Weber, B
    Weiss, T
    JOURNAL OF VASCULAR SURGERY, 1997, 25 (03) : 537 - 544
  • [4] A PROSPECTIVE DOUBLE-BLIND TRIAL OF INTRACORPOREAL PAPAVERINE VERSUS PROSTAGLANDIN-E1 IN THE TREATMENT OF IMPOTENCE
    SAROSDY, MF
    HUDNALL, CH
    ERICKSON, DR
    HARDIN, TC
    NOVICKI, DE
    JOURNAL OF UROLOGY, 1989, 141 (03): : 551 - 553
  • [5] TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE IN STAGE-IIB WITH INTERMITTENT SHORT-TERM INFUSION OF PROSTAGLANDIN-E1
    ZANKE, BW
    HACH, W
    OZEN, Y
    SAUERWEIN, G
    VASA-JOURNAL OF VASCULAR DISEASES, 1987, : 36 - 38
  • [6] EFFECTS OF REGULAR PHYSICAL-TRAINING IN A SUPERVISED CLASS AND ADDITIONAL INTRAVENOUS PROSTAGLANDIN-E1 AND NAFTIDROFURYL INFUSION THERAPY IN PATIENTS WITH INTERMITTENT CLAUDICATION - A CONTROLLED-STUDY
    DIEHM, C
    KUHN, A
    STRAUSS, R
    HUBSCHMULLER, C
    KUBLER, W
    PROSTAGLANDIN E1 IN VASCULAR DISEASE, 1989, 28 : 26 - 30
  • [7] EFFECTS OF REGULAR PHYSICAL-TRAINING IN A SUPERVISED CLASS AND ADDITIONAL INTRAVENOUS PROSTAGLANDIN-E1 AND NAFTIDROFURYL INFUSION THERAPY IN PATIENTS WITH INTERMITTENT CLAUDICATION - A CONTROLLED-STUDY
    DIEHM, C
    KUHN, A
    STRAUSS, R
    HUBSCHMULLER, C
    KUBLER, W
    VASA-JOURNAL OF VASCULAR DISEASES, 1989, : 26 - 30
  • [8] Randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of AS-013, a prostaglandin E-1 prodrug, in patients with intermittent claudication
    Belch, JJF
    Bell, PRF
    Creissen, D
    Dormandy, JA
    Kester, RC
    McCollum, RD
    Mizushima, Y
    Ruckley, CV
    Scurr, JH
    Wolfe, JHN
    CIRCULATION, 1997, 95 (09) : 2298 - 2302
  • [9] Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease
    Grossman, Paul Michael
    Mendelsohn, Farrell
    Henry, Timothy D.
    Hermiller, James B.
    Litt, Marc
    Saucedo, Jorge F.
    Weiss, Robert J.
    Kandzari, David E.
    Kleiman, Neal
    Anderson, R. David
    Gottlieb, Daniel
    Karlsberg, Ronald
    Snell, Jeffery
    Rocha-Singh, Krishna
    AMERICAN HEART JOURNAL, 2007, 153 (05) : 874 - 880
  • [10] CLINICAL EFFECTS OF INTRAVENOUSLY ADMINISTERED PROSTAGLANDIN-E1 IN PATIENTS WITH REST PAIN DUE TO PERIPHERAL OBLITERATIVE ARTERIAL-DISEASE (POAD) - A PRELIMINARY-REPORT ON A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
    DIEHM, C
    STAMMLER, F
    HUBSCHMULLER, C
    ECKSTEIN, HH
    SIMINI, B
    VASA-JOURNAL OF VASCULAR DISEASES, 1987, : 52 - 56
12